Science flutes: CU-30101 has obtained drug market authorization from the National Medical Products Administration.

The company announced on the Hong Kong Stock Exchange that the group's CU-30101 has obtained the drug marketing approval from the National Medical Products Administration of the People's Republic of China. CU-30101 is a topical Lidocaine and Prilocaine combination cream used for local anesthesia in dermatological surgery.